Navigation Links
Mayo Clinic study guides physicians using therapeutic cooling to treat cardiac arrest patients
Date:10/19/2011

ROCHESTER, Minn. - Sudden cardiac arrest is the leading cause of death in the United States, and just 7 percent of victims survive that initial collapse. In addition, fewer than half of the small percentage of people whose hearts are restarted survive to leave the hospital, because they often suffer irreversible brain damage. A Mayo Clinic study published this month in the journal Neurology provides guidance to physicians using therapeutic cooling to treat sudden cardiac arrest patients.

One relatively new approach to prevent or reduce brain damage involves the use of hypothermia - forced cooling - of the patient as soon as possible following sudden cardiac arrest. The aim is to slow the body's metabolism and reduce the cascade of undesirable events that can cause permanent brain damage. It is believed that mild therapeutic hypothermia suppresses harmful chemical reactions in the brain and preserves cell health.

One concern about the use of hypothermia for cardiac arrest patients is that it might delay a patient's post-event awakening. This is important because an evaluation 72 hours after the patient's collapse is useful in determining the prognosis, especially if the patient is awake.

Mayo Clinic researchers, however, found that both patient groups - those who were and were not treated with therapeutic hypothermia - awoke an average of two days post-collapse, with nearly all patients in both groups awakening within three days.

"After sudden cardiac arrest, the use of therapeutic hypothermia can make a difference, not only in terms of survival but also allowing more patients to recover without significant brain damage," says senior author Alejandro Rabinstein, M.D., a Mayo Clinic neurologist. "Our study relieves concerns about delayed awakening associated with hypothermia and supports its use when indicated."

In addition to these findings, the researchers also report that:

  • The median day of awakening was day two for both hypothermic and non-hypothermic patients.
  • Ninety-one percent of hypothermic patients and 79 percent of non-hypothermic patients awoke within three days following their collapse.
  • Overall in-hospital mortality was 53 percent.

Also reported was that:

  • Sixty-four percent of patients treated with induced hypothermia survived.
  • Just 24 percent of patients not treated with hypothermia survived.


'/>"/>

Contact: Brian Kilen
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. The West Clinic Joins Cancer Clinics of Excellence (CCE)
2. Stethoscope App gives iPhone New Clinical Skills
3. Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota
4. Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US
5. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
6. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
7. Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
10. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
11. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of Happy ... their novel lifesaving device for the everyday use of parents worldwide. It is ... to read a child’s vital signs, and detect unusual symptoms or physical patterns. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the Renaissance ... program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish we ... entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. Ted ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, ... neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it ... as the product advances towards regulatory and clinical phases. , "This is another ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Viverae ® , a leader in workplace ... IBM ® Watson Campaign Automation, implementing behavioral messaging ... a personalized experience. Through digital engagement, the platform prompts ... real time. The enhanced experience drives engagement by focusing ... they are in their journey to health. ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
(Date:4/18/2017)... April 18, 2017  Socionext Inc. and SOINN ... in 2016, in which Socionext extracts and delivers ... companies achieved initial results in reading ultrasound images ... Brain SOINN. The results will be introduced at ... 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology: